Alnylam Pharmaceuticals, Inc.

RNAi therapeutics company with commercial rare-disease products and a late-stage cardiometabolic pipeline.

Back to company catalog

Cardiovascular & rare disease · RNA interference (RNAi) therapeutics · Commercial + Phase 3

Compare report options